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Introduction
Protease-activated receptor-1 (PAR1), a G protein–coupled re-
ceptor (GPCR) for thrombin, is important for hemostasis and 
thrombosis, infl  ammation, embryonic development, and cancer 
progression (Coughlin, 2005; Arora et al., 2007). Unlike most 
GPCRs, PAR1 is irreversibly activated by proteolysis. The PAR1 
N terminus is cleaved by thrombin, which unmasks a new N ter-
minus that acts as a tethered ligand and binds intramolecularly 
to the receptor to trigger transmembrane signaling (Vu et al., 
1991). Synthetic peptides that mimic the newly formed N terminus 
can activate PAR1 independently of proteolysis. Because of the 
irreversible proteolytic nature of PAR1 activation, rapid desen-
sitization and receptor traffi  cking tightly regulate PAR1 signaling 
(Trejo et al., 1998; Paing et al., 2002; Chen et al., 2004).
PAR1 displays two modes of traffi  cking that are impor-
tant for the regulation of receptor signaling. Unactivated PAR1 
constitutively cycles between the cell surface and an intracellular 
compartment, generating an intracellular pool of uncleaved re-
ceptor that replenishes the cell surface after thrombin exposure 
and leads to rapid resensitization to thrombin signaling inde-
pendent of de novo receptor synthesis (Hein et al., 1994; Paing 
et al., 2006). Unlike most GPCRs, which internalize and recycle, 
activated PAR1 is internalized, sorted directly to lysosomes, 
and degraded (Hoxie et al., 1993; Trejo and Coughlin, 1999). 
Sorting of activated PAR1 to lysosomes is critical for signal ter-
mination (Trejo et al., 1998). Constitutive and agonist-induced 
PAR1 internalization are clathrin and dynamin dependent (Trejo 
et al., 2000). However, in contrast to most GPCRs, neither con-
stitutive nor activated PAR1 internalization requires arrestins 
(Paing et al., 2002). Arrestins interact with clathrin and adaptor 
protein complex-2 (AP2) to facilitate the internalization of acti-
vated GPCRs through clathrin-coated pits (Goodman et al., 
1996; Laporte et al., 1999). We recently showed that AP2 and 
not arrestins is critical for PAR1 constitutive internalization and 
is essential for the cellular recovery of thrombin signaling 
(Paing et al., 2006). Interestingly, activated PAR1 internalization 
through clathrin-coated pits is independent of AP2, suggesting 
that constitutive and activated receptor internalization require 
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rotease-activated receptor-1 (PAR1), a G protein–
coupled receptor (GPCR) for thrombin, is irreversibly 
activated by proteolysis. Consequently, PAR1 traf-
ﬁ   cking is critical for the ﬁ   delity of thrombin signaling. 
PAR1 displays constitutive and agonist-induced internal-
ization, which are clathrin and dynamin dependent but 
are independent of arrestins. The clathrin adaptor AP2 
(adaptor protein complex-2) is critical for constitutive 
but not for activated PAR1 internalization. In this study, we 
show that ubiquitination negatively regulates PAR1 con-
stitutive internalization and speciﬁ  es a distinct clathrin 
adaptor requirement for activated receptor internalization. 
PAR1 is basally ubiquitinated and deubiquitinated after 
activation. A PAR1 lysineless mutant signaled normally but 
was not ubiquitinated. Constitutive internalization of ubiq-
uitin (Ub)-deﬁ  cient PAR1 was markedly increased and 
inhibited by the fusion of Ub to the cytoplasmic tail. 
Ub-deﬁ  cient PAR1 constitutive internalization was AP2 de-
pendent like the wild-type receptor. However, unlike wild-
type PAR1, AP2 was required for the internalization of 
activated Ub-deﬁ  cient receptor, suggesting that the inter-
nalization of ubiquitinated PAR1 requires different endo-
cytic machinery. These studies reveal a novel function for 
ubiquitination in the regulation of GPCR internalization.
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different endocytic machinery. The mechanisms that regulate 
activated PAR1 internalization through clathrin-coated pits is 
not known.  
Ubiquitin (Ub) modifi  cation of integral membrane pro-
teins can function as an internalization and endosomal sorting 
signal (Hicke and Dunn, 2003). Ub, a 76–amino acid protein, is 
recognized by Ub-binding domains (UBDs), which are found in 
proteins of the endocytic sorting machinery. Ubiquitination reg-
ulates internalization of the yeast Ste2 and Ste3 GPCRs. Studies 
using yeast strains that lack specifi  c Ub-conjugating enzymes 
and Ub-defective Ste2 mutants or chimeras indicate that mono-
ubiquitination is both necessary and suffi  cient for constitutive 
and agonist-induced receptor internalization (Hicke and Riezman, 
1996; Terrell et al., 1998). In contrast, recent studies suggest 
that mammalian GPCR ubiquitination is essential for lyso-
somal sorting but not for receptor internalization (Marchese and 
Benovic, 2001; Shenoy et al., 2001). Direct β2-adrenergic 
receptor (β2AR) ubiquitination is not required for internalization 
but regulates activated receptor lysosomal sorting and degra-
dation (Shenoy et al., 2001). Similar to β2AR, ubiquitination 
of chemokine receptor 4 (CXCR4) is essential for agonist-
promoted receptor lysosomal degradation but not for internal-
ization (Marchese and Benovic, 2001). Although ubiquitination 
does not have a direct role in mammalian GPCR internalization, 
it has been shown to function indirectly. Indeed, activation-
dependent ubiquitination of arrestins is required for β2AR inter-
nalization (Shenoy et al., 2001). However, the function of 
ubiquitination in the regulation of mammalian GPCRs that do 
not require arrestins for endocytosis is not known.
We have shown that constitutive and agonist-induced 
PAR1 internalization is clathrin and dynamin dependent and in-
dependent of arrestins (Paing et al., 2002). We recently found 
that the clathrin adaptor AP2 is critical for constitutive but not 
for agonist-induced PAR1 internalization (Paing et al., 2006). 
Given these observations and the previous fi  ndings that Ub reg-
ulates yeast GPCR internalization (Hicke and Riezman, 1996; 
Terrel et al., 1998), we examined the function of ubiquitination 
in PAR1 traffi  cking. Our fi  ndings here reveal a novel role for 
ubiquitination in the negative regulation of PAR1 constitutive 
internalization and in specifying a distinct clathrin adaptor 
requirement for activated receptor internalization.
Results
Basal ubiquitination and agonist-induced 
deubiquitination of PAR1
To defi  ne the importance of the posttranslational modifi  cation 
of lysine residues with Ub in the regulation of PAR1 traffi  cking, 
we constructed a PAR1 lysineless mutant by replacing the 10 
intracytosolic lysine (K) residues with arginines, which is des-
ignated PAR1 0K (Fig. 1 A). To ensure that the PAR1 0K mu-
tant was not globally disrupted in receptor function, the capacity 
Figure 1.  PAR1 wild-type and lysineless 0K mutant signaling and ubiqui-
tination. (A) The PAR1 intracytosolic lysine (K) residues that serve as poten-
tial sites for ubiquitination are highlighted and were mutated to arginine to 
generate a PAR1 0K mutant. (B) HeLa cells stably expressing FLAG-tagged 
PAR1 wild type (Wt) and 0K mutant labeled with myo-[
3H]inositol were in-
cubated with various concentrations of α-thrombin for 10 min at 37°C in 
media with lithium chloride. The amounts of accumulated [
3H]IPs were then 
measured. The data shown (mean ± SD [error bars]; n = 3) are expressed 
as the fold increase in [
3H]IP accumulation over basal counts per minute 
from one experiment and are representative of three separate experiments. 
The values for PAR1 wild-type and 0K mutant cell surface expression were 
0.385 ± 0.023 and 0.376 ± 0.044, respectively. (C) HEK293 cells tran-
siently transfected with either FLAG-tagged PAR1 wild type or 0K mutant 
together with HA-tagged Ub and dynamin K44A mutant were incubated 
with or without 100 μM TRAP for 10 min at 37°C. Cells were lysed and 
immunoprecipitated with M2 anti-FLAG antibody, and ubiquitinated PAR1 
was detected by immunoblotting with an anti-HA antibody conjugated to 
HRP. Membranes were stripped and probed with an anti-FLAG polyclonal 
antibody to detect PAR1. Cell lysates were immunoblotted for dynamin 
(Dyn) expression to control for differences in transfection efﬁ  ciency and for 
actin to control for sample loading. The asterisk indicates detection of the 
immunoprecipitating antibody heavy and light chains. Similar ﬁ  ndings 
were observed in three independent experiments.UBIQUITIN REGULATION OF GPCR INTERNALIZATION • WOLFE ET AL. 907
of the activated receptor to promote Gαq-stimulated phospho-
inositide hydrolysis was examined. HeLa cells expressing com-
parable amounts of cell surface PAR1 wild type and 0K mutant 
were incubated with various concentrations of thrombin, and 
the amounts of [
3H]inositol phosphates (IPs) formed were then 
measured (Fig. 1 B). Both PAR1 wild type and 0K mutant were 
equally effective at stimulating [
3H]IP accumulation as well 
as at inducing a maximal effect at saturating concentrations 
of thrombin. The ability of the PAR1 0K mutant to couple to 
G protein activation like the wild-type receptor indicates that 
receptor function is intact.
We next determined whether the receptor was modifi  ed 
with Ub by directly comparing the ubiquitination status of PAR1 
wild type to the lysineless 0K mutant. HEK293 cells transiently 
coexpressing similar amounts of PAR1 wild type or 0K mutant 
together with HA-tagged Ub and dynamin K44A were incu-
bated in the absence or presence of agonist peptide for 10 min at 
37°C. Cells were lysed, PAR1 was immunoprecipitated, and the 
extent of receptor ubiquitination was determined. Strikingly, in 
untreated cells, wild-type PAR1 displayed a substantial amount 
of basal ubiquitination that was detected as prominent high 
molecular weight species migrating above  107 kD (Fig. 1 C, 
lane 1), which is consistent with the addition of multiple HA-
tagged Ubs. Remarkably, incubation with agonist decreased 
wild-type PAR1 ubiquitination (Fig. 1 C, lane 2). In contrast 
to wild-type receptor, ubiquitinated species of PAR1 0K were 
undetectable in both untreated or agonist-treated cells (Fig. 1 C, 
lanes 3 and 4). These findings suggest that PAR1 is basally 
ubiquitinated and that activation promotes deubiquitination.
Ub-deﬁ  cient PAR1 displays enhanced 
constitutive internalization
To investigate the function of ubiquitination in PAR1 traffi  cking, 
we examined the constitutive and agonist-induced loss of cell 
surface wild-type and Ub-deficient PAR1 by ELISA. HeLa 
cells and Rat1 fi  broblasts stably expressing similar amounts 
of surface PAR1 wild type or 0K mutant were incubated 
with M1 anti-FLAG antibody for 1 h at 4°C to label cell 
surface receptors and were treated with or without agonist 
for various times at 37°C, and the amount of receptor remain-
ing on the cell surface was then quantifi  ed by ELISA. In wild-
type PAR1–expressing cells, agonist induced rapid receptor 
Figure 2.  Internalization of wild-type and Ub-
  deﬁ  cient PAR1. (A–D) HeLa cells and Rat1 ﬁ  broblasts 
stably expressing similar amounts of cell surface PAR1 
wild type (Wt) or 0K mutant were incubated with M1 
anti-FLAG antibody for 1 h at 4°C such that only cell 
surface receptors bound antibody. Cells were then in-
cubated in media with (A and C) or without (B and D) 
100 μM TRAP for various times at 37°C. Cells were 
ﬁ  xed, and the amount of receptor remaining at the cell 
surface was quantiﬁ  ed by ELISA. The data (mean ± 
SD [error bars]; n = 3) are expressed as the fraction 
of initial cell surface antibody bound at 0 min and 
are representative of three separate experiments. The 
difference between PAR1 wild-type and 0K constitutive 
internalization at various times was signiﬁ  cant (**, P < 
0.01; ***, P < 0.005). (E) HeLa cells expressing PAR1 
wild type, 0K mutant, or pBJ vector control were incu-
bated in the absence or presence of 100 μM TRAP for 
15 min at 37°C, ﬁ  xed, permeabilized, and immuno-
stained for PAR1 (green) using anti-FLAG polyclonal 
antibody and for the early endosome marker EEA1 (red) 
using monoclonal anti-EEA1 antibody. The cells were 
then imaged by confocal microscopy. Colocalization 
of PAR1 with EEA1 is shown as yellow in the merged 
image. The insets are magniﬁ  cations of the boxed 
areas. Bars, 10 μm.JCB • VOLUME 177 • NUMBER 5 • 2007  908
internalization within 10 min, and the receptor continued to 
slowly internalize, leading to an  70% loss of surface PAR1 
after 30 min (Fig. 2, A and C). PAR1 0K mutant internalization 
was comparable with wild-type receptor after agonist expo-
sure in both cell types (Fig. 2, A and C). We next examined the 
constitutive internalization of wild-type PAR1 and observed 
a slow rate of internalization resulting in a 10–20% loss of 
cell surface receptor after 30 min (Fig. 2, B and D), which is 
consistent with that previously reported for these cell types 
(Shapiro et al., 1996; Paing et al., 2004). In contrast, Ub-defi  cient 
PAR1 0K mutant displayed an increased rate of constitutive 
internalization in which 50–60% of receptor was lost from 
the cell surface after 30 min of incubation in both cell types 
(Fig. 2, B and D). Immunofl  uorescence microscopy studies 
also revealed a substantial amount of internalized Ub-defi  cient 
PAR1 0K mutant in early endosomes compared with wild-
type receptor even without agonist exposure or antibody pre-
binding (Fig. 2 E), suggesting that the absence of ubiquitination 
enhances PAR1 constitutive internalization. In contrast, both 
PAR1 wild type and 0K mutant showed robust internalization 
after agonist exposure (Fig. 2 E).
To confi  rm the enhanced constitutive internalization of 
Ub-defi  cient PAR1, we used a receptor-bound antibody cap-
ture assay as a measure of receptor internalization. HeLa cells 
expressing similar amounts of surface PAR1 wild type or 0K 
mutant were labeled with antibody at 4°C and incubated in 
the absence or presence of agonist for the indicated times at 
37°C. After incubation, antibody bound to cell surface receptor 
was stripped, cells were lysed, and the amount of internalized 
receptor-bound antibody was quantifi  ed by ELISA. In wild-
type PAR1–expressing cells,  10% of antibody that initially 
bound to cell surface receptor was internalized at the steady 
state (Fig. 3 A), whereas virtually no internalized antibody was 
detected in untransfected cells (not depicted). Remarkably, 
PAR1 0K mutant displayed an increased rate of constitutive 
internalization, with  50% of receptor-bound antibody inter-
nalized after 15 min (Fig. 3 A). Agonist caused a robust in-
crease in PAR1 wild-type internalization, whereas activated 
PAR1 0K mutant internalization was comparable with consti-
tutive internalization (Fig. 3 B). A minimal amount of constitu-
tively internalized wild-type PAR1 was detected in endosomes 
by immunofl  uorescence microscopy, whereas PAR1 0K mu-
tant showed substantial redistribution to endosomes in the ab-
sence of agonist (Fig. 3 C). The addition of agonist triggered 
comparable wild-type and Ub-defi  cient PAR1 internalization 
(Fig. 3 C). Together, these fi  ndings provide further evidence 
that the absence of ubiquitination increases PAR1 constitu-
tive internalization.
To defi  ne the lysine residues that are important for PAR1 
internalization, we examined mutants in which lysines in the 
fi  rst or third intracytosolic loops or cytoplasmic tail (C tail) 
were mutated to arginines. A mutant PAR1 in which the four 
C-tail lysine residues were replaced with arginines (4K/R) dis-
played an enhanced rate of constitutive internalization similar 
to Ub-defi  cient PAR1 (Fig. 3), whereas PAR1 intracytosolic 
loop lysine mutants internalized like wild-type receptor (not 
depicted). However, the extent of constitutive internalization 
displayed by PAR1 4K/R was less than that observed with PAR1 
0K mutant, indicating that in addition to PAR1 C-tail  lysines, 
other lysine residues or regulatory domains may contribute to 
constitutive internalization. To test the role of individual C-tail 
Figure 3.  PAR1 C-tail lysine residue mutations enhance constitutive inter-
nalization. (A and B) HeLa cells stably expressing similar amounts of PAR1 
wild type (Wt), 0K, or 4K/R mutant were labeled with M1 anti-FLAG anti-
body for 1 h at 4°C, washed, and incubated in media for various times at 
37°C (A) or with or without 100 μM TRAP for 15 min at 37°C (B). After 
incubations, cells were stripped of antibody remaining bound to the cell 
surface, and internalized antibody bound to receptor was quantiﬁ  ed by 
ELISA. Data (mean ± SD [error bars]; n = 3) are expressed as the fraction 
of initial cell surface receptor-bound antibody determined at 0 min and are 
representative of three separate experiments. The difference between PAR1 
wild-type and 4K/R mutant constitutive internalization at various times was 
signiﬁ  cant (***, P < 0.005). (C) HeLa cells expressing PAR1 wild type and 
0K mutant labeled with polyclonal anti-FLAG antibody were either left 
untreated (0 min) or incubated in the absence (constitutive) or presence of 
100 μM TRAP for 10 min at 37°C, ﬁ  xed, and processed. Cells were immuno-
stained for PAR1 and imaged by confocal microscopy. These images are 
representative of many cells examined in three independent experiments. 
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lysines in PAR1 internalization, we constructed receptor mu-
tants in which K
407, K
421, and K
422 (3K/R) or K
421 and K
422 (2K/R) 
were converted to arginines (Fig. 4 A). The rate of PAR1 3K/R 
and 2K/R constitutive internalization was increased substantially 
compared with wild-type receptor (Fig. 4 B), suggesting that 
the distal K
421 and K
422 are important for constitutive internal-
ization. PAR1 3K/R and 2K/R also showed marked redistri-
bution to endosomes compared with wild-type receptor in 
immunofl  uorescence microscopy studies (Fig. 4 D), whereas 
agonist caused a similar increase in wild-type and mutant re-
ceptor internalization (Fig. 4, C and D). These data suggest that 
K
421 and K
422 residues are critical for the regulation of PAR1 
constitutive internalization.
We next examined whether PAR1 C-tail lysines were im-
portant for receptor ubiquitination. HEK293 cells transiently 
coexpressing HA-tagged PAR1 wild type, 4K/R, and 2K/R to-
gether with FLAG-Ub and dynamin K44A were treated with or 
without agonist for 10 min at 37°C, and the extent of receptor 
ubiquitination was examined. In untreated cells, the major ubiq-
uitinated PAR1 wild-type species migrated above  107 kD, 
whereas minor species were detected below  94 kD (Fig. 5, 
lane 1), which is consistent with multiple ubiquitinated PAR1 
species. Strikingly, the addition of agonist caused a marked de-
crease in wild-type PAR1 ubiquitination (Fig. 5, lane 1). In con-
trast to wild-type receptor, basal ubiquitination of both PAR1 
4K/R and 2K/R C-tail mutants was substantially reduced ir-
respective of agonist addition (Fig.  5, lanes 3–6). Together, these 
data suggest that the PAR1 C-tail K
421 and K
422 residues are the 
major sites for receptor ubiquitination.
Figure 4.  PAR1 3K/R and 2K/R display enhanced constitutive internali-
zation. (A–C) HeLa cells expressing PAR1 wild type (Wt) or C-tail lysine 
mutants as depicted in A were labeled with M1 anti-FLAG antibody and 
incubated in the media only (B) for various times at 37°C or with or with-
out 100 μM TRAP (C) for 15 min at 37°C. Cells were processed, and 
PAR1 internalization was quantiﬁ  ed as described in Fig. 3. The data 
(mean ± SD [error bars]; n = 3) shown are representative of three 
  independent experiments. The difference between PAR1 wild-type and 
K/R mutant constitutive internalization at various times was signiﬁ  cant 
(**, P < 0.01; ***, P < 0.005). (D) PAR1 wild type–, 3K/R–, and 2K/
R–  expressing HeLa cells labeled with anti-FLAG polyclonal antibody were 
either left untreated (0 min) or were incubated without (constitutive) or with 
100 μM TRAP for 10 min at 37°C, processed, and imaged by confocal 
microscopy. Bars, 10 μm.
Figure 5.  PAR1 C-tail lysine residues are major sites of ubiquitination. 
HEK293 cells were transiently transfected with either HA-tagged PAR1 
wild type (Wt), 4K/R, 2K/R, or pcDNA together with FLAG-tagged 
Ub and dynamin K44A and were incubated in the absence or presence 
of 100 μM TRAP for 10 min at 37°C. Cells were lysed and immuno-
precipitated with anti-HA polyclonal antibody, and ubiquitinated PAR1 
was detected with M2 anti-FLAG conjugated to HRP. Membranes were 
stripped and probed with an anti-HA monoclonal antibody conjugated 
to HRP to detect PAR1. Cell lysates were immunoblotted for dynamin 
and actin as controls. These data are representative of at least three inde-
pendent experiments.JCB • VOLUME 177 • NUMBER 5 • 2007  910
Ub fused to the C tail of PAR1 0K mutant 
inhibits constitutive internalization
Our results suggest an important regulatory role for the ubiqui-
tination of C-tail lysines in PAR1 internalization. Therefore, we 
tested whether constitutive internalization was affected when 
Ub was fused in frame to the C tail of the PAR1 0K Ub-defi  cient 
mutant. We used a modifi  ed Ub in which K
48 was mutated to 
  arginine (K48R), and the two terminal glycine residues (∆GG) 
were deleted to avoid extensive modifi  cation of Ub and to in-
crease the effi  ciency of PAR1 0K–Ub chimera expression at 
the cell surface. We fi  rst examined PAR1 wild-type and mutant 
  expression in transfected HeLa cells by immunoblotting using 
anti-PAR1 antibodies. As expected, PAR1 wild type and 0K 
mutant appeared as one broad major transfection–dependent 
band migrating between  64 and 98 kD (Fig. 6 A), which is in-
dicative of posttranslational glycosylation of the receptor pro-
tein as previously reported (Vouret-Craviari et al., 1995). The 
PAR1 0K–Ub chimera migrated as two high molecular weight 
species, which is consistent with the appearance of multiple 
ubiquitinated receptor species (Fig. 6 A). PAR1 0K mutant dis-
played an increased rate of constitutive internalization (Fig. 6 B). 
In contrast, the attachment of Ub to the C tail of the PAR1 0K 
mutant reduced the rate of constitutive internalization com-
parable with that observed with wild-type PAR1 (Fig. 6 B). The 
addition of agonist induced similar increases in PAR1 wild type, 
0K mutant, and 0K–Ub chimera internalization, indicating that 
activated PAR1 0K–Ub internalization remained intact (Fig. 6 C). 
Immunofl  uorescence microscopy studies were consistent with 
a marked inhibition of PAR1 0K–Ub chimera constitution inter-
nalization compared with Ub-defi  cient PAR1, whereas agonist 
induced a comparable increase in wild-type and mutant receptor 
internalization (Fig. 6 D). Together, these data suggest that 
modifi  cation of PAR1 0K with Ub negatively regulates con-
stitutive internalization.
Figure 6.  Ub fused to the C tail of PAR1 0K mutant markedly inhibits con-
stitutive internalization. (A) HeLa cells expressing similar amounts of PAR1 
wild type (Wt), 0K mutant, or 0K–Ub K48R ∆GG chimera were lysed, 
immunoprecipitated with M2 anti-FLAG antibody, and immunoblotted for 
PAR1 using a polyclonal anti-PAR1 antibody. Asterisks indicate unpro-
cessed PAR1. These data are representative of three different experiments. 
(B and C) HeLa cells expressing PAR1 wild type, 0K mutant, or 0K–Ub chi-
mera labeled with M1 anti-FLAG antibody were incubated in media only 
(B) for various times at 37°C or with or without 100 μM TRAP (C) for 15 min 
at 37°C. Cells were processed, and receptor internalization was quantiﬁ  ed 
as described in Fig. 3. The data (mean ± SD [error bars]; n = 3) shown 
are representative of three independent experiments. (D) HeLa cells ex-
pressing PAR1 wild type, 0K mutant, or 0K–Ub chimera labeled with anti-
FLAG polyclonal antibody were either left untreated (0 min) or treated in 
the absence (constitutive) or presence of 100 μM TRAP for 10 min at 37°C, 
ﬁ  xed, processed, and imaged by confocal microscopy. Bars, 10 μm.
Figure 7.  Ub-deﬁ  cient PAR1 mutant displays normal recycling. HeLa cells 
expressing PAR1 wild type (Wt) or 0K mutant labeled with M1 anti-FLAG 
antibody were incubated in media without agonist for 30 min at 37°C to 
facilitate constitutive internalization. Cells were stripped of surface-bound 
antibody, and the amount of receptor-bound antibody reappearing at the 
cell surface was measured after various recovery times. Surface receptor-
bound antibody was quantitated after the initial 4°C labeling (t0), after 
30-min incubation at 37°C in the absence of agonist (t1), and after the 
indicated times of recovery. The data (mean ± SD [error bars]; n = 3) are 
expressed as follows: (amount of receptor-bound antibody at the indicated 
time points)/(amount of receptor-bound antibody at t0). Data are represent-
ative of three separate experiments.UBIQUITIN REGULATION OF GPCR INTERNALIZATION • WOLFE ET AL. 911
Ubiquitination of PAR1 negatively regulates 
constitutive internalization but not 
receptor recycling
The endosomal accumulation of Ub-defi  cient PAR1 may be 
caused by an increased rate of constitutive internalization as 
well as to an inability of the PAR1 0K mutant to recycle back to 
the cell surface. To address this possibility, we examined the inter-
nalization and recycling of wild-type and Ub-defi  cient PAR1. 
HeLa cells expressing PAR1 wild type or 0K mutant were la-
beled with antibody at 4°C and incubated for 30 min at 37°C to 
facilitate constitutive internalization. After incubation, surface-
bound antibody was stripped, and the recovery of previously 
internalized receptor-bound antibody was followed for various 
times. An initial 30-min incubation at 37°C caused an  25% 
decrease in the amount of PAR1 wild type, whereas a substan-
tially greater amount ( 50%) of PAR1 0K mutant was initially 
lost from the cell surface (Fig. 7, t1), which is consistent with an 
increased rate of constitutive internalization. In both PAR1 
wild-type– and 0K mutant–expressing cells, a comparable amount 
of previously internalized receptor recycled back to the cell 
surface (Fig. 7). These results are consistent with the previously 
described extent of constitutive internalization and recycling of 
PAR1 (Trejo and Coughlin, 1999) and indicate that PAR1 
re  cycling is not attenuated with Ub-defi  cient PAR1.
Internalization of Ub-deﬁ  cient PAR1 
is clathrin and dynamin dependent
We next examined whether Ub-defi   cient PAR1 internalized 
through a clathrin- and dynamin-dependent pathway like wild-
type receptor (Trejo et al., 2000). HeLa cells expressing PAR1 
wild type or 0K mutant were transiently transfected with GFP-
tagged dynamin wild type, K44A, or vector, and the amounts of 
cell surface receptor at steady state were measured. In PAR1 
wild-type–expressing cells, neither dynamin wild-type nor 
K44A mutant expression affected the amounts of cell surface 
receptor expression when compared with vector (Fig. 8 A). The 
amount of surface PAR1 0K mutant was also comparable in 
  dynamin wild-type and vector-transfected cells. In contrast, the 
Figure 8.  Internalization of Ub-deﬁ   cient PAR1 is 
clathrin and dynamin dependent. (A and B) PAR1 wild 
type (Wt)– and 0K mutant–expressing HeLa cells were 
transiently transfected with GFP-tagged dynamin wild 
type, K44A mutant, or pcDNA (A) or with 50 nM 
siRNA targeted to either clathrin heavy chain (CHC) 
or nonspeciﬁ  c (ns) mRNA sequences (B). In B, the inset 
conﬁ  rms the loss of clathrin protein in CHC siRNA–
transfected cells as detected by immunoblotting. After 
transfection, the amount of PAR1 residing on the cell 
surface at steady state was measured by ELISA. The 
data (mean ± SD [error bars]; n = 3) are expressed 
as the fold increase over surface PAR1 expression 
detected in vector or ns-siRNA–transfected cells and 
are representative of three independent experiments. 
A signiﬁ  cant difference in surface expression between 
PAR1 wild type and 0K mutant was detected in K44A 
mutant–transfected cells and CHC siRNA–transfected 
cells (**, P < 0.01). (C and D) PAR1 wild type– and 
0K mutant–expressing HeLa cells transiently trans-
fected with GFP-tagged K44A mutant (C) or 50 nM ns- 
or CHC siRNA (D) were incubated in the absence 
(constitutive) or presence of 100 μM TRAP for 10 min 
at 37°C. Cells were ﬁ  xed, immunostained for PAR1 or 
clathrin, and imaged by confocal microscopy. These 
images are representative of many cells examined in 
three separate experiments. In cells not expressing dy-
namin K44A, PAR1 wild type and 0K mutant localize 
to the cell surface and endocytic vesicles in the absence 
of agonist (arrowheads), whereas in agonist-treated 
cells, PAR1 wild type and 0K are retained predomi-
nantly on the cell surface in dynamin K44A–expressing 
cells (arrowheads). Bars, 10 μm.JCB • VOLUME 177 • NUMBER 5 • 2007  912
coexpression of dynamin K44A increased PAR1 0K expression 
detected on the cell surface compared with wild-type receptor 
or vector (Fig. 8 A). In immunofl  uorescence microscopy studies, 
the constitutive internalization of PAR1 wild type and 0K 
mutant were virtually abolished in K44A-expressing cells, 
whereas in adjacent untransfected cells, PAR1-containing endo-
somes were clearly evident (Fig. 8 C, arrowheads). Internaliza-
tion of activated PAR1 wild type and 0K mutant were similarly 
inhibited by dynamin K44A (Fig. 8 C, arrowheads), suggesting 
that wild-type and Ub-defi  cient PAR1 internalization are dyna-
min dependent.
To determine the role of clathrin in Ub-defi  cient PAR1 
internalization, we used siRNA targeting the clathrin heavy chain 
(CHC) to deplete HeLa cells of endogenous clathrin. The ex-
pression of CHC was considerably decreased in cells transiently 
transfected with siRNA specifi  cally targeting CHC compared 
with nonspecifi  c control (Fig. 8 B, inset). In control siRNA-
transfected cells, PAR1 wild-type and Ub-defi  cient 0K mutant 
surface levels were comparable. In contrast, the amount of 
PAR1 0K mutant surface expression was considerably increased 
in CHC siRNA–transfected cells compared with wild-type 
receptor, which is consistent with the inhibition of Ub-defi  cient 
PAR1 constitutive internalization (Fig. 8 B). Constitutive and 
agonist-induced internalization of wild-type and Ub-defi  cient 
PAR1 was virtually ablated in CHC siRNA–transfected cells 
compared with control cells as assessed by immunofl  uorescence 
microscopy (Fig. 8 D). Together, these fi  ndings are consistent 
with a clathrin- and dynamin-dependent regulation of wild-type 
and Ub-defi  cient PAR1 internalization.
Ubiquitination speciﬁ  es a distinct 
clathrin adaptor requirement 
for activated PAR1 internalization
We recently reported that the clathrin adaptor AP2 function is 
critical for constitutive but not agonist-induced internalization 
of wild-type PAR1 (Paing et al., 2006). To assess AP2 function 
in Ub-defi  cient PAR1 internalization, we used siRNA targeting 
the μ2 subunit to deplete cells of the endogenous AP2 com-
plex (Fig. 9, A [inset] and C). In PAR1 wild-type–expressing 
cells, constitutive internalization was completely inhibited in 
μ2-siRNA–transfected cells compared with nonspecifi  c (ns) 
siRNA control cells (Fig. 9 A). The PAR1 0K mutant displayed 
enhanced constitutive internalization in ns-siRNA control cells, 
which was virtually abolished in μ2-siRNA–transfected cells 
(Fig. 9 B), strongly suggesting a critical role for AP2 in both 
wild-type and Ub-defi  cient PAR1 constitutive internalization. 
In ns-siRNA control cells, agonist caused the substantial inter-
nalization of wild-type PAR1 that was partially diminished in 
μ2-siRNA–transfected cells (Fig. 9 A), indicating that even 
in the absence of AP2, activated wild-type PAR1 is capable 
Figure 9.  AP2 function is critical for constitu-
tive and agonist-induced internalization of Ub-
deﬁ  cient PAR1. (A and B) HeLa cells expressing 
PAR1 wild type (Wt; A) or 0K mutant (B) were 
transiently transfected with 50 nM siRNA tar-
geted to either μ2 or nonspeciﬁ   c (ns) mRNA 
sequences. Cells prelabeled with M1 anti-
FLAG antibody were then incubated in the ab-
sence (constitutive) or presence of 100 μM 
TRAP for 10 min at 37°C, and the amount of 
receptor remaining on the cell surface was 
quantiﬁ   ed by ELISA. The data (mean ± SD 
[error bars]; n = 3) shown are representative 
of three independent experiments. In A, the 
inset conﬁ   rms the loss of AP2 in μ2-siRNA–
transfected cells, whereas actin expression was 
unaffected. The difference between constitutive 
and agonist-induced PAR1 internalization in 
ns-siRNA– and μ2-siRNA–transfected cells was 
signiﬁ   cant (**, P < 0.01). (C) HeLa cells 
  expressing PAR1 wild type or 0K mutant 
transiently transfected with 50 nM of ns- or 
μ2-siRNA were incubated in the absence 
(constitutive) or presence of 100 μM TRAP for 
10 min at 37°C. Cells were ﬁ  xed, processed, 
and immunostained for PAR1 or β2-adaptin 
and imaged by confocal microscopy. The images 
shown are representative of many cells ob-
served in at least three different experiments. 
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of internalization. Remarkably, activated PAR1 0K mutant inter-
nalization was virtually abolished in μ2-siRNA–transfected cells, 
suggesting that AP2 function is critical for agonist-induced Ub-
defi  cient PAR1 internalization (Fig. 9 B). Immunofl  uorescence 
microscopy experiments of PAR1 0K mutant–expressing cells 
were consistent with a critical role for AP2 in activated Ub-
defi   cient receptor internalization. In the absence of agonist 
  exposure, PAR1 wild type and 0K mutant failed to redistribute to 
endosomes in AP2-depleted cells (Fig. 9 C). In contrast, agonist 
peptide caused a marked increase in wild-type PAR1 internal-
ization in μ2-siRNA–transfected cells comparable with siRNA 
control cells (Fig. 9 C), which is consistent with an AP2-
  independent pathway for activated wild-type PAR1 internaliza-
tion. In contrast, activated PAR1 0K mutant internalization was 
markedly inhibited in μ2-siRNA–transfected cells (Fig. 9 C), 
suggesting a critical role for AP2 in agonist-promoted Ub-
defi  cient PAR1 internalization. Together, these data suggest a novel 
function for ubiquitination in specifying a distinct clathrin adaptor 
requirement for activated PAR1 internalization.
Ubiquitination of PAR1 is not required 
for agonist-induced lysosomal degradation
We next determined whether ubiquitination functions in   agonist-
induced PAR1 lysosomal degradation by comparing the extent of 
wild-type versus Ub-defi  cient PAR1 degradation after prolonged 
agonist exposure. HeLa cells stably expressing similar amounts 
of surface PAR1 wild type or 0K mutant were incubated with or 
without agonist for 90 min at 37°C, and the amount of receptor 
remaining was then measured. Remarkably, the extent of acti-
vated Ub-defi  cient PAR1 degradation was comparable with that 
observed with wild-type receptor (Fig. 10 A), suggesting that 
PAR1 ubiquitination is not required for lysosomal degradation. 
To confi  rm Ub-independent degradation of PAR1, we examined 
receptor degradation in Rat1 fi  broblasts. PAR1 wild-type and 0K 
mutant exhibited a comparable,  60% loss of receptor protein 
after prolonged agonist exposure (Fig. 10 B), which is consistent 
with the extent of PAR1 degradation previously reported in these 
cell types (Trejo and Coughlin, 1999; Trejo et al., 2000). These 
fi  ndings suggest a Ub-independent pathway for agonist-induced 
PAR1 lysosomal sorting and degradation.
Discussion
In this study, we have defi  ned a novel function for ubiquitination 
in the negative regulation of PAR1 constitutive internalization 
and in specifying a distinct clathrin adaptor requirement for acti-
vated receptor internalization. We demonstrate that PAR1 is 
ubiquitinated under basal conditions and deubiquitinated after 
activation. The ubiquitination of PAR1 appears to negatively 
regulate constitutive internalization. This is supported by our 
fi  ndings that the constitutive internalization of PAR1 is mark-
edly increased in the absence of ubiquitination and is inhibited 
by the fusion of Ub to the C tail of Ub-defi  cient PAR1. Several 
GPCRs, including the yeast Ste2 and Ste3 receptors, have been 
reported to be basally ubiquitinated at the plasma membrane, 
similar to PAR1. However, in contrast to PAR1, the ubiqui-
tination of Ste2 and Ste3 receptors promotes constitutive and 
  agonist-induced internalization (Hicke and Riezman, 1996; Terrell 
et al., 1998). The mammalian platelet-activating receptor GPCR 
has also been shown to be basally ubiquitinated, but the role of 
ubiquitination in receptor internalization was not examined 
(Dupre et al., 2003). Our studies also suggest that the ubiquitination 
of PAR1 specifi  es a distinct clathrin adaptor requirement for 
activated receptor internalization that is not critically dependent 
on AP2. We found that AP2 function was required for the consti-
tutive internalization of both wild-type and Ub-defi  cient PAR1. 
Strikingly, AP2 function was also critical for the internalization 
of activated Ub-defi  cient PAR1, whereas the internalization of 
activated wild-type receptor occurred in the absence of AP2. We 
also demonstrate that ubiquitination is not essential for agonist-
promoted PAR1 lysosomal degradation. Thus, our fi  ndings with 
PAR1 suggest a novel function for ubiquitination in the regula-
tion of GPCR traffi  cking in mammalian cells.
The ubiquitination of PAR1 is likely a highly dynamic 
and reversible process, and, under basal conditions, the receptor 
Figure 10.  Agonist-induced degradation of Ub-deﬁ  cient PAR1. (A and B) 
PAR1 wild type (Wt)– and 0K mutant–expressing HeLa cells (A) and Rat1 
ﬁ  broblasts (B) were incubated in the absence or presence of 100 μM TRAP 
for either 90 or 60 min at 37°C, respectively. Cells were lysed and immuno-
precipitated with M2 anti-FLAG antibody, and the amount of PAR1 remain-
ing was detected by immunoblotting. Untransfected (UT) HeLa cells or Rat1 
ﬁ  broblast controls are shown in adjacent lanes. Asterisks indicate unpro-
cessed PAR1. The data shown (mean ± SEM [error bars]) in the bar graphs 
are expressed as the fraction of PAR1 remaining compared with untreated 
cells and represent the mean of three separate experiments.JCB • VOLUME 177 • NUMBER 5 • 2007  914
probably exists as a ubiquitinated and deubiquitinated species. 
Our fi  ndings raise the intriguing possibility that the ubiquitina-
tion of PAR1 might affect the ability of AP2 to regulate consti-
tutive internalization. We previously reported that a PAR1 
tyrosine-based motif (Y
420KKL
423) localized at the extreme 
C terminus directly binds to the μ2 subunit of AP2 using surface 
plasmon resonance (Paing et al., 2006). Moreover, both the μ2 sub-
unit and the tyrosine-based motif are essential for promoting 
PAR1 constitutive internalization in multiple cell types. In this 
study, we show that the highly conserved K
421 and K
422 residues 
located within the PAR1 C-tail tyrosine-based motif are the 
major sites of ubiquitination and negatively regulate constitutive 
internalization, suggesting that receptor ubiquitination at these 
sites might affect AP2 binding. In addition, the fusion of Ub to 
the C tail of Ub-defi  cient PAR1 0K mutant places the Ub moi-
ety within fi  ve residues of the tyrosine-based motif, which could 
also affect AP2 binding and, thereby, diminish constitutive 
internalization. However, the low micromolar affi  nity binding 
of the PAR1 C tail with the μ2 subunit is typical of μ2 subunit 
weak interactions with proteins bearing tyrosine-based motifs 
and has precluded our ability to directly test the role of ubiqui-
tination in PAR1 and AP2 interaction in cells using coimmuno-
precipitations or pull downs. Thus, we cannot exclude the 
possibility that other ubiquitination sites or regulatory domains 
could also contribute to the regulation of PAR1 constitutive 
internalization. It is also possible that the ubiquitinated PAR1 
conformation is simply not compatible with AP2 interaction 
or that ubiquitinated PAR1 is bound to another protein impor-
tant for localization at the plasma membrane. Regardless, our 
fi  ndings suggest that PAR1 ubiquitination provides a mecha-
nism to retain the majority of the receptor at the cell surface so 
that it is readily available for proteolytic activation by extra-
cellular proteases.
PAR1 ubiquitination also appears to have a critical role in 
specifying a distinct clathrin adaptor requirement for activated 
receptor internalization. Several clathrin adaptors, including 
epsins and eps15, contain UBDs that recognize ubiquitinated 
cargo and facilitate clathrin-dependent internalization. Interest-
ingly, the yeast homologues of the mammalian epsins Ent1 and 
Ent2 contain UBDs and facilitate the endocytosis of ubiqui-
tinated Ste2 receptor (Chen et al., 1998; Shih et al., 2002). In 
mammalian cells, epsin is ubiquitinated under basal conditions, 
which may prevent its interaction with AP2, clathrin, and mem-
brane lipids, and the deubiquitination of epsin appears to en-
hance its endocytic activity (Chen and De Camilli, 2005). Ub 
may also negatively regulate epsin function by binding to its 
UBDs intramolecularly, similar to other endocytic adaptor pro-
teins (Hoeller et al., 2006). In Drosophila melanogaster, the 
deubiquitinating enzyme Fat facets/USP9X regulates Delta/
Notch receptor internalization by deubiquitinating Liquid facets, 
a homologue of epsin, which is consistent with a function 
for epsin deubiquitination in the regulation of receptor endo-
cytosis (Cadavid et al., 2000; Chen et al., 2002). In contrast, the 
ubiquitination of arrestins is critical for the internalization of 
certain GPCRs (Shenoy et al., 2001). However, arrestins are not 
essential for PAR1 internalization (Paing et al., 2002), suggesting 
that activated PAR1 internalization may require epsins similar 
to the Ste2 receptor. However, whether epsin and/or Ub regula-
tion of epsin is important for PAR1 internalization remains to 
be determined.
A role for ubiquitination in mammalian GPCR lysosomal 
sorting and degradation has been demonstrated. Agonist-
  induced ubiquitination of β2AR and CXCR4 is critical for 
lysosomal degradation but is not required for internalization 
(Marchese and Benovic, 2001; Shenoy et al., 2001). The Ub 
moiety on CXCR4 is thought to interact with UBDs in some 
endocytic adaptor proteins, such as hepatocyte growth factor–
  regulated kinase substrate (Hrs), to be effi  ciently degraded 
in the lysosome (Marchese et al., 2003). Hrs interacts with 
Tsg101 (tumor suppressor gene product 101) and promotes 
the assembly of a multiprotein ESCRT (endosomal sorting 
complex required for transport) complex that binds and sorts 
ubiquitinated cargo into the involuting membrane of multi-
vesicular endosomes in a highly coordinated manner (Raiborg 
et al., 2003). In contrast to β2AR and CXCR4, the ubiquitination 
of PAR1 is not required for agonist-induced lysosomal de-
gradation because Ub-defi  cient PAR1 is degraded comparably 
with wild-type receptor in HeLa cells and Rat1 fi  broblasts. 
A δ opioid receptor mutant lacking all intracytosolic lysines was 
also shown to undergo effi  cient agonist-induced degradation, 
indicating that lysosomal degradation of certain GPCRs occurs 
independently of ubiquitination (Tanowitz and Von Zastrow, 
2002). We show that after activation, PAR1 is deubiquitinated, 
suggesting that deubiquitinated rather than ubiquitinated receptor 
transits through the endocytic sorting pathway to lysosomes 
for degradation (Fig. 10). Moreover, we recently reported that 
agonist-induced PAR1 lysosomal degradation is independent of 
Hrs and Tsg101 but requires sorting nexin 1 (Gullapalli et al., 
2006), which is consistent with a Ub-independent PAR1 lyso-
somal sorting pathway. These data, in conjunction with the 
ability of the Ub-defi  cient PAR1 mutant to be effi  ciently de-
graded, strongly suggest that the conventional Ub-dependent 
ESCRT-mediated pathway is not required for agonist-induced 
PAR1 lysosomal sorting and degradation. However, we cannot 
exclude the possibility that the ubiquitination of PAR1 has a 
role in basal turnover of the receptor. The effi  cient traffi  cking of 
proteolytically activated PAR1 to lysosomes is essential for the 
termination of receptor signaling (Trejo et al., 1998); thus, fur-
ther delineation of the lysosomal sorting pathway of activated 
PAR1 is important.
Our studies reveal a novel function for ubiquitination in 
the negative regulation of PAR1 constitutive internalization and 
in specifying a distinct clathrin adaptor requirement for acti-
vated receptor internalization. PAR1 is uniquely activated by 
proteolytic cleavage that results in irreversible activation, un-
like normal ligand-activated GPCRs. Thus, rapid desensitiza-
tion and receptor traffi  cking tightly regulate PAR1 signaling. 
We have shown that PAR1 traffi  cking does not require arrestins 
and is essential for the disposal of irreversibly activated receptor 
and for replenishing the cell surface with uncleaved receptor 
after protease exposure. The novel regulation of PAR1 inter-
nalization by ubiquitination has a critical role in these distinct 
endocytic pathways. Interestingly, the regulation of PAR1 inter-
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because the ubiquitination of PAR2, a second protease-activated 
GPCR, functions in lysosomal degradation but not in receptor 
internalization (Jacob et al., 2005). Unlike PAR1, arrestins 
are required for PAR2 internalization (Stalheim et al., 2005). 
However, whether other GPCRs that do not require arrestins 
for endocytic sorting are similarly regulated by ubiquitination 
remains to be determined. Our studies provide new insight into 
novel mechanisms by which ubiquitination functions in the 
endocytic sorting of GPCRs in mammalian cells. The challenge 
is to now identify the physiologically relevant Ub ligases and 
deubiquitinating enzymes that function in PAR1 traffi  cking.
Materials and methods
Reagents and antibodies
Human  α-thrombin was obtained from Enzyme Research Laboratories. 
Thrombin receptor–activating peptides (TRAPs), SFLLRN, and T  F  L  L  R  N  P  N  D  K   
were synthesized as the carboxyl amide and puriﬁ   ed by reverse-phase 
high pressure liquid chromatography (University of North Carolina Peptide 
Facility, Chapel Hill, NC).
Monoclonal M1 and M2 anti-FLAG and polyclonal anti-FLAG anti-
bodies and the anti–β-actin antibody were purchased from Sigma-Aldrich. 
Monoclonal anti-HA antibody conjugated to HRP was obtained from 
Roche, and polyclonal anti-HA was obtained from Covance. Anti-PAR1 
rabbit polyclonal antibody was previously described (Paing et al., 2006). 
The anti-AP50 (μ2), anti–β2 adaptin, anti–early endosomal antigen-1 
(EEA1), and anti-CHC monoclonal antibodies were purchased from BD 
Biosciences. Antidynamin monoclonal antibody was obtained from Santa 
Cruz Biotechnology, Inc. HRP-conjugated goat anti–mouse and goat anti–
rabbit antibodies were purchased from Bio-Rad Laboratories. Alexa-
Fluor488 and -594-conjugated anti–mouse and anti–rabbit antibodies 
were obtained from Invitrogen.
cDNAs and cell lines
A human PAR1 cDNA containing an N-terminal FLAG or HA epitope was 
used to generate mutants. Mutations were introduced by site-directed muta-
genesis using the QuikChange Mutagenesis kit (Stratagene) and conﬁ  rmed 
by dideoxy sequencing. PAR1 0K and K/R mutants were generated by re-
placing intracytosolic lysine (K) residues with arginine (R). A PAR1 0K mu-
tant with Ub fused in frame to the C tail was generated as follows. A Pm1I 
site was introduced at the 3′ end of the PAR1 0K C tail and positioned such 
that the PmlI sequence, CACGTG, coincided with the native stop codon. 
A SacII site was introduced in the 3′ untranslated region 21 bp from the PmlI 
site. PCR ampliﬁ  cation was then used to generate the Ub cDNA fragment 
with the 5′ Pm1I site and 3′ SacII sites. A 222-bp PmlI–SacII fragment en-
coding Ub containing a K
48 to R
48 mutation and glycine deletions was then 
ligated in frame using PAR1 0K 3′ end compatible sites. PAR1 and Ub coding 
regions were separated by a spacer sequence, HVV. Insertion of Ub in frame 
after the PAR1 0K C tail was conﬁ  rmed by dideoxy sequencing.
HeLa cells and Rat1 ﬁ  broblasts stably expressing PAR1 wild type 
and mutants were generated and maintained as previously described 
(Trejo et al., 1998, 2000). HeLa cells were transiently transfected with 
a total plasmid amount of 0.4 μg per 24 wells, 0.8 μg per 12 wells, and 
2 μg per six wells using LipofectAMINE reagent (Invitrogen) according to 
the manufacturer’s instructions and were assayed 48 h after transfection. 
HEK293 cells plated at  1 × 10
6 cells per 10-cm
2 dish were transiently 
transfected with a total of 7.4 μg of plasmids (consisting of 5 μg of PAR1, 
0.4 μg of tagged Ub, and 2 μg of dynamin K44A) using FuGene-6 re-
agent or LipofectAMINE as described previously (Marchese and Benovic, 
2001) and according to the manufacturer’s instructions. Cells were then split 
into 6-cm plates and assayed 48 h after transfection.
siRNAs
HeLa cells were transiently transfected with 50 nM of ns or μ2-speciﬁ  c 
siRNAs using LipofectAMINE 2000 according to the manufacturer’s 
instructions. The μ2-siRNA targeting the mRNA sequence 5′-G  T  G  G  A  T  G  C-
C  T  T  T  C  G  G  G  T  C  A  -3′ and the ns-siRNA 5′-C  T  A  C  G  T  C  C  A  G  G  A  G  C  G  C  A  C  C  -3′ 
were previously described (Paing et al., 2006). The CHC siRNA targeting 
the mRNA sequence 5′-G  C  A  A  T  G  A  G  C  T  G  T  T  T  G  A  A  G  A  -3′ was used at 50 nM 
and was previously described (Huang et al., 2004). All siRNAs were syn-
thesized by Dharmacon.
Phosphoinositide hydrolysis
HeLa cells stably expressing PAR1 wild type or 0K mutant were labeled 
with 1.0 μCi/ml  myo-[
3H]inositol (American Radiolabeled Chemicals), 
and accumulated [
3H]IPs were measured as previously described (Paing 
et al., 2002).
Immunoﬂ  uorescence confocal microscopy
HeLa cells stably expressing PAR1 wild type or mutants were processed, 
ﬁ  xed, permeabilized, and immunostained with species-speciﬁ  c secondary 
antibodies conjugated to AlexaFluor488 or -594 and were mounted in Fluor-
Save reagent (Calbiochem) and imaged by confocal microscopy as we 
previously described (Paing et al., 2002). Images were acquired using a 
laser-scanning confocal imaging system (FluoView 300; Olympus) con-
ﬁ  gured with a ﬂ  uorescence microscope (IX70; Olympus) ﬁ  tted with a 
planApo 60× NA 1.4 oil objective (Olympus). Confocal images (x-y section 
at 0.28 μm) were collected sequentially at 800 × 600 resolution with 
2× optical zoom using FluoView software at room temperature. The ﬁ  nal 
composite image was created using Photoshop 7.0 (Adobe).
Internalization and recycling assays
Constitutive and agonist-induced PAR1 internalization were assessed using 
our previously described assays for loss of surface receptor and receptor-
bound antibody uptake (Paing et al., 2002, 2004). PAR1 recycling was 
measured as we previously described (Trejo and Coughlin, 1999).
PAR1 ubiquitination and degradation
HEK293 cells transiently transfected with FLAG-tagged PAR1 wild type or 
mutants, HA- or FLAG-tagged Ub, and dynamin K44A were incubated with 
or without agonists and lysed in buffer containing 50 mM Tris-HCl, pH 7.4, 
150 mM NaCl, 2 mM EDTA, pH 8.0, 0.5% (wt/vol) sodium deoxycholate, 
0.1% (vol/vol) NP-40, 0.1% (wt/vol) SDS, 100 μM sodium orthovana-
date, 20 mM N-ethylmaleimide, and protease inhibitor tablet (Roche). 
Equivalent amounts of protein lysates were then immunoprecipitated with 
M2 anti-FLAG or anti-HA antibody. Immunoprecipitates were resolved by 
SDS-PAGE, transferred to nitrocellulose membranes, and probed with an 
anti-HA or M2 anti-FLAG antibody conjugated to HRP. Blots were then 
stripped and probed with a polyclonal anti-FLAG or -HA antibody to detect 
PAR1. Immunoblots were developed with ECL (GE Healthcare) and imaged 
by autoradiography. PAR1 degradation was determined in HeLa cells and 
Rat1 ﬁ  broblast cells stably expressing the PAR1 wild type or mutants as 
previously described (Trejo and Coughlin, 1999; Trejo et al., 2000).
Data analysis
Data were analyzed using Prism 4.0 software (GraphPad), and statistical 
signiﬁ  cance was determined using InStat 3.0 (GraphPad). Group compari-
sons were made using an unpaired t test.
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